Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?
Tenaya Therapeutics Ownership Summary
Tenaya Therapeutics is owned by 0.03% institutional investors, 0.72% insiders, and 99.25% retail investors. Column group is the largest institutional shareholder, holding 10.91% of TNYA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.66% of its assets in Tenaya Therapeutics shares.
TNYA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tenaya Therapeutics | 0.03% | 0.72% | 99.25% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Column group | 9.40M | 10.91% | $13.44M |
| Blackrock funding, inc. /de | 5.30M | 6.15% | $7.57M |
| Casdin capital | 6.73M | 6.13% | $3.84M |
| Jpmorgan chase | 5.16M | 5.98% | $7.37M |
| Blackrock | 4.07M | 5.03% | $12.63M |
| Vanguard group | 3.27M | 3.80% | $4.68M |
| Ghost tree capital | 1.35M | 1.67% | $4.18M |
| Geode capital management | 1.27M | 1.47% | $1.81M |
| Vr adviser | 1.56M | 1.42% | $886.82K |
| State street | 1.05M | 1.30% | $3.25M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 9.40M | 24.12% | $13.44M |
| Ghost tree capital | 1.35M | 1.31% | $4.18M |
| Stepstone group lp | 462.16K | 0.58% | $660.89K |
| Casdin capital | 6.73M | 0.31% | $3.84M |
| Euclidean capital | 1.02M | 0.20% | $1.45M |
| Alphabet | 915.71K | 0.08% | $1.31M |
| Vr adviser | 1.56M | 0.08% | $886.82K |
| Trustees of columbia university in the city of new york | 291.83K | 0.03% | $166.34K |
| Atticus wealth management | 47.76K | 0.02% | $68.30K |
| Virtu financial | 104.71K | 0.01% | $150.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 5.16M | 0.00% | 5.13M |
| Blackrock funding, inc. /de | 5.30M | 0.00% | 1.19M |
| Ghost tree capital | 1.35M | 1.31% | 575.00K |
| Ubs group | 478.51K | 0.00% | 452.37K |
| Susquehanna group, llp | 146.76K | - | 136.42K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -6.98M |
| Price t rowe associates inc /md/ | 136.23K | - | -2.89M |
| Octagon capital advisors lp | - | - | -2.58M |
| Integral health asset management | - | - | -2.38M |
| Fmr | 34.67K | - | -1.31M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sei investments | 69.70K | 0.00% | 69.70K | $99.67K |
| Dafna capital management | 47.32K | 0.01% | 47.32K | $26.98K |
| Commonwealth equity services | 44.50K | 0.00% | 44.50K | $64.00K |
| Spire wealth management | 36.90K | 0.00% | 36.90K | $52.77K |
| Mariner | 21.02K | 0.00% | 21.02K | $30.06K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -11.00 |
| Capital performance advisors llp | -12.00 |
| Advisor group | -38.00 |
| Srs capital advisors | -105.00 |
| Federated hermes | -414.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 2 | -97.70% | 32,748 | -99.92% | - | 0.00% | 1 | -97.92% | 1 | -94.74% |
| Dec 31, 2024 | 49 | -47.31% | 18,984,954 | -67.06% | 22 | 0.49% | 29 | -43.14% | 9 | -47.06% |
| Sep 30, 2024 | 93 | -3.13% | 57,630,897 | 1.33% | 66 | 1.36% | 51 | -5.56% | 17 | -37.04% |
| Jun 30, 2024 | 96 | 6.67% | 56,876,265 | 1.89% | 70 | 1.23% | 54 | 12.50% | 27 | 3.85% |
| Mar 31, 2024 | 90 | 20.00% | 55,822,180 | 19.53% | 75 | 1.90% | 48 | 33.33% | 26 | 4.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 2.10M | 2.66% | -471.71K |
| T. Rowe Price New Horizons | 2.10M | 2.65% | -441.00 |
| Fidelity Select Biotechnology | 1.75M | 2.20% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.88M | 1.77% | 100.00 |
| JPMorgan US Small Company L | 785.69K | 0.91% | -315.70K |
| iShares Russell 2000 ETF | 1.41M | 0.86% | 687.00 |
| JPMorgan Small Cap Value I | 1.37M | 0.84% | - |
| T. Rowe Price New Horizons Tr-Z | 554.73K | 0.70% | 9.11K |
| Vanguard Institutional Extnd Mkt Idx Tr | 748.15K | 0.46% | - |
| abrdn Life Sciences Investors | 600.70K | 0.37% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Higa Tomohiro | SVP, Finance | Sell | $615.35 |
| May 16, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | $1.30K |
| May 16, 2025 | Ali Faraz | Chief Executive Officer | Sell | $1.41K |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell | $333.81 |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell | $547.55 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 3 |
| 2025 Q1 | 6 | 8 |
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | 7 |
| 2024 Q1 | 2 | 7 |
TNYA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools